InMed Pharmaceuticals Short Interest Ratio and Short Volume

-0.07 (-3.40 %)
(As of 09/17/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume81,600 shs
Average Volume131,751 shs
Market Capitalization$17.79 million
P/E RatioN/A
Dividend YieldN/A

InMed Pharmaceuticals (NASDAQ:INM) Short Interest Data

Current Short Volume7,300 shares
Previous Short Volume96,600 shares
Change Vs. Previous Month-92.44%
Dollar Volume Sold Short$16,133.00
Short Interest Ratio / Days to Cover0.1
Last Record DateAugust, 31 2021
Outstanding Shares8,941,000 shares
Float Size7,990,000 shares
Short Percent of Float0.09%
Today's Trading Volume81,600 shares
Average Trading Volume131,751 shares
Today's Volume Vs. Average-38.06%

Short Interest Over Time

Days to Cover Over Time

Percentage of Float Shorted Over Time

cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling InMed Pharmaceuticals ?

Sign up to receive the latest short interest report for InMed Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

InMed Pharmaceuticals (NASDAQ:INM) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
8/31/20217,300 shares $16,133.00 -92.4%0.1%0.1 $2.21
8/13/202196,600 shares $231,840.00 -47.8%1.2%1.4 $2.40
7/30/2021185,100 shares $516,429.00 +98.2%2.3%2.6 $2.79
7/15/202193,400 shares $249,378.00 +396.8%1.2%1.3 $2.67
6/30/202118,800 shares $59,784.00 +37.2%0.2%0.2 $3.18
6/15/202113,700 shares $39,045.00 -2.8%0.2%0.2 $2.85
5/28/202114,100 shares $41,595.00 +30.6%0.2%0.2 $2.95
5/14/202110,800 shares $30,348.00 -90.7%0.1%0.1 $2.81
4/30/2021115,800 shares $431,934.00 -14.7%1.5%0.7 $3.73
4/15/2021135,800 shares $435,918.00 -64.8%1.7%0.7 $3.21
3/31/2021385,200 shares $1.21 million -6.6%4.8%1.8 $3.13
3/15/2021412,600 shares $1.96 million +0.3%5.2%1.8 $4.75
2/26/2021411,400 shares $1.80 million +7.3%5.9%1.7 $4.37
2/12/2021383,500 shares $2.05 million +177.1%5.5%1.6 $5.35
1/29/2021138,400 shares $546,693.84 +63.2%2.0%0.6 $3.95
1/15/202184,800 shares $367,184.00 No Change1.2%0.7 $4.33

InMed Pharmaceuticals (NASDAQ:INM) Short Interest FAQ

speech bubbles
speech bubbles

What is InMed Pharmaceuticals' current short interest?

Short interest is the volume of InMed Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of August 31st, traders have sold 7,300 shares of INM short. 0.09% of InMed Pharmaceuticals' shares are currently sold short. Learn More on InMed Pharmaceuticals' current short interest.

What is a good short interest percentage for InMed Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.09% of InMed Pharmaceuticals' floating shares are currently sold short.

Is InMed Pharmaceuticals' short interest increasing or decreasing?

InMed Pharmaceuticals saw a decrease in short interest in August. As of August 31st, there was short interest totaling 7,300 shares, a decrease of 92.4% from the previous total of 96,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is InMed Pharmaceuticals' float size?

InMed Pharmaceuticals currently has issued a total of 8,941,000 shares. Some of InMed Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. InMed Pharmaceuticals currently has a public float of 7,990,000 shares.

How does InMed Pharmaceuticals' short interest compare to its competitors?

0.09% of InMed Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to InMed Pharmaceuticals: Vaccinex, Inc. (4.84%), Longeveron Inc. (8.01%), Regulus Therapeutics Inc. (0.00%), Celyad Oncology SA (0.00%), Rezolute, Inc. (0.05%), Monopar Therapeutics Inc. (1.03%), Synthetic Biologics, Inc. (0.02%), Merrimack Pharmaceuticals, Inc. (2.50%), Cellectar Biosciences, Inc. (0.00%), and Reviva Pharmaceuticals Holdings, Inc. (0.90%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Square, Inc. ($9.81 billion), S&P Global Inc. ($7.52 billion), Advanced Micro Devices, Inc. ($7.18 billion), Charter Communications, Inc. ($6.21 billion), Wayfair Inc. ($4.60 billion), Zoom Video Communications, Inc. ($3.23 billion), Uber Technologies, Inc. ($3.11 billion), Palo Alto Networks, Inc. ($2.74 billion), Teladoc Health, Inc. ($2.52 billion), and Etsy, Inc. ($2.16 billion). View all of the most shorted stocks.

What does it mean to sell short InMed Pharmaceuticals stock?

Short selling INM is an investing strategy that aims to generate trading profit from InMed Pharmaceuticals as its price is falling. InMed Pharmaceuticals' stock is trading down $0.07 today. To short InMed Pharmaceuticals stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that InMed Pharmaceuticals will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against InMed Pharmaceuticals?

A short squeeze for InMed Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of INM, which in turn drives the price of the stock up even further.

How often is InMed Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INM, twice per month. The most recent reporting period available is August, 31 2021.

This page was last updated on 9/20/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.